Reshape Lifesciences Inc (RSLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -26,129 | -19,948 | -14,234 | -6,732 | -25,781 |
| Depreciation Amortization | 312 | 242 | 166 | 86 | 374 |
| Accounts receivable | 15 | 18 | 18 | 18 | 27 |
| Accounts payable and accrued liabilities | 267 | -76 | 60 | 147 | 61 |
| Other Working Capital | 113 | -30 | 218 | -491 | 1,018 |
| Other Operating Activity | 6,037 | 4,839 | 3,197 | 1,373 | 5,876 |
| Operating Cash Flow | $-19,384 | $-14,955 | $-10,575 | $-5,601 | $-18,426 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -89 | -27 | -9 | -7 | -416 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 200 |
| Investing Cash Flow | $-89 | $-27 | $-9 | $-7 | $-216 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 12,079 | 11,152 | 11,150 | 7,863 | 24,079 |
| Other Financing Activity | -4,285 | -3,198 | -2,198 | -1,116 | -4,448 |
| Financing Cash Flow | $7,794 | $7,954 | $8,952 | $6,747 | $19,630 |
| Beginning Cash Position | 23,298 | 23,298 | 23,298 | 23,298 | 22,309 |
| End Cash Position | 11,619 | 16,270 | 21,665 | 24,436 | 23,298 |
| Net Cash Flow | $-11,678 | $-7,028 | $-1,632 | $1,139 | $989 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,384 | -14,955 | -10,575 | -5,601 | -18,426 |
| Capital Expenditure | -89 | -27 | -9 | -7 | -416 |
| Free Cash Flow | -19,472 | -14,982 | -10,584 | -5,608 | -18,842 |